PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Yeungnam University Journal of Medicine10.12701/yujm.2019.001432019362115-123Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapyJinju Oh, Ki Ho Seol, Youn Seok Choi, Jeong Won Lee, Jin Young Baehttp://yujm.yu.ac.kr/upload/pdf/yujm-2019-00143.pdf, http://yujm.yu.ac.kr/journal/view.php?doi=10.12701/yujm.2019.00143, http://yujm.yu.ac.kr/upload/pdf/yujm-2019-00143.pdf
Surgical Science10.4236/ss.2012.31009220120310463-468Prognostic Impact of Carcinoembryonic Angtigen (CEA) in Locally Advanced Cervical Cancer Treated with Concurrent ChemoradiotherapyKiyosumi Shibata, Hiroaki Kajiyama, Mik Mizuno, Eiko Yamamoto, Fumitaka Kikkawahttp://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/ss.2012.310092, http://www.scirp.org/journal/doi.aspx?DOI=10.4236/ss.2012.310092, http://www.scirp.org/journal/doi.aspx?DOI=10.4236/ss.2012.310092
Journal of Gynecologic Oncology10.3802/jgo.2019.30.e692019303Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapySeung-Hyuk Shimhttps://synapse.koreamed.org/pdf/10.3802/jgo.2019.30.e69, https://synapse.koreamed.org/DOIx.php?id=10.3802/jgo.2019.30.e69, https://synapse.koreamed.org/DOIx.php?id=10.3802/jgo.2019.30.e69
European Journal of Cancer Supplements10.1016/s1359-6349(07)71209-0200754321-3225037 POSTER Pelvic node control in locally advanced uterine cervical cancer treated with concurrent chemoradiotherapyT. Toita, W. Tamaki, Y. Nagai, K. Ogawa, S. Gibo, Y. Kakinohana, M. Hirakawa, K. Kamiyama, Y. Aoki, S. Murayamahttps://api.elsevier.com/content/article/PII:S1359634907712090?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634907712090?httpAccept=text/plain
Gynecologic Oncology10.1016/j.ygyno.2018.02.00120181483437-438Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancerMatthew M. Harkenrider, Basel Altoos, William Smallhttps://api.elsevier.com/content/article/PII:S0090825818301100?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825818301100?httpAccept=text/plain
Gynecologic Oncology10.1016/j.ygyno.2016.04.084201614123Comparison of the prognostic value of F-18 PET metabolic parameters of primary tumors and regional lymph nodes in patients with locally advanced cervical cancer who are treated with concurrent chemoradiotherapyG.O. Chong, Y.H. Lee, D.G. Hong, Y.S. Lee, Y.L. Chohttp://api.elsevier.com/content/article/PII:S0090825816302189?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0090825816302189?httpAccept=text/plain
BMC Cancer10.1186/s12885-018-4210-32018181Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinomaJiraporn Setakornnukul, Kullathorn Thephamongkholhttp://link.springer.com/content/pdf/10.1186/s12885-018-4210-3.pdf, http://link.springer.com/article/10.1186/s12885-018-4210-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12885-018-4210-3.pdf
Lung Cancer10.1016/0169-5002(94)94461-x199411178Longterm survival results for patients with locally advanced non-small cell lung carcinoma (NSCLC) treated with aggressive concurrent chemoradiotherapy. (CT/TRT)https://api.elsevier.com/content/article/PII:016950029494461X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029494461X?httpAccept=text/plain
Radiotherapy and Oncology10.1016/s0167-8140(11)70911-2201199S310789 poster CONCURRENT CHEMORADIOTHERAPY WITH HIGH-DOSE-RATE BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCERY.S. Kim, J.H. Kim, S.W. Lee, S.M. Yoon, S.D. Ahn, E.K. Choihttps://api.elsevier.com/content/article/PII:S0167814011709112?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814011709112?httpAccept=text/plain
European Journal of Cancer10.1016/s0959-8049(13)70040-6201349S16-S17AOSP29 POSTERIOR CERVICAL LYMPH NODE METASTASIS AS VALUABLE PROGNOSTIC FACTORS FOR STAGE IVA–IVB NASOPHARYNGEAL CARCINOMA TREATED WITH INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIOTHERAPYJ. Setakornnukul, S. Rojwatkarnjana, K. Thephamongkhol, Y. Chansilpahttps://api.elsevier.com/content/article/PII:S0959804913700406?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804913700406?httpAccept=text/plain